Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McKee

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
Clinical and Experimental Dermatology|November 1, 1989
A timed study of the histopathology, direct immunofluorescence and ultrastructural findings in idiopathic cold-contact urticaria over a 24-h periodF Lawlor, A Kobza Black, A S Breathnach, et al.
Journal of Medicinal Chemistry|August 5, 1994
Structure-based design of HIV-1 protease inhibitors: replacement of two amides and a 10 pi-aromatic system by a fused bis-tetrahydrofuranA K Ghosh, W J Thompson, P M Fitzgerald, et al.
Heart (British Cardiac Society)|June 17, 2005
Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failureS J Leslie, J C S Spratt, S P McKee, et al.
Craniomaxillofacial Trauma & Reconstruction|April 25, 2025
Fracture Patterns in Craniofacial Gunshot Wounds: A Seven-Year ExperienceGabriela G Cruz, Sameer H Siddiqui, David Z Allen, et al.
Transactions of the American Ophthalmological Society|January 1, 1992
The classification of amblyopia on the basis of visual and oculomotor performanceS P McKee, C M Schor, S B Steinman, et al.
Journal of Medicinal Chemistry|April 15, 1994
The development of cyclic sulfolanes as novel and high-affinity P2 ligands for HIV-1 protease inhibitorsA K Ghosh, H Y Lee, W J Thompson, et al.
Drug Design and Discovery|January 1, 1993
HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimeticsA K Ghosh, S P McKee, W M Sanders, et al.
Journal of Medicinal Chemistry|April 2, 1993
Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitorsA K Ghosh, W J Thompson, H Y Lee, et al.
Journal of Medicinal Chemistry|August 6, 1993
Potent HIV protease inhibitors: the development of tetrahydrofuranylglycines as novel P2-ligands and pyrazine amides as P3-ligandsA K Ghosh, W J Thompson, M K Holloway, et al.
Journal of Medicinal Chemistry|January 22, 1993
3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitorsA K Ghosh, W J Thompson, S P McKee, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Clinical and Experimental Dermatology|November 1, 1989
A timed study of the histopathology, direct immunofluorescence and ultrastructural findings in idiopathic cold-contact urticaria over a 24-h periodF Lawlor, A Kobza Black, A S Breathnach, et al.
Journal of Medicinal Chemistry|August 5, 1994
Structure-based design of HIV-1 protease inhibitors: replacement of two amides and a 10 pi-aromatic system by a fused bis-tetrahydrofuranA K Ghosh, W J Thompson, P M Fitzgerald, et al.
Heart (British Cardiac Society)|June 17, 2005
Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failureS J Leslie, J C S Spratt, S P McKee, et al.
Craniomaxillofacial Trauma & Reconstruction|April 25, 2025
Fracture Patterns in Craniofacial Gunshot Wounds: A Seven-Year ExperienceGabriela G Cruz, Sameer H Siddiqui, David Z Allen, et al.
Transactions of the American Ophthalmological Society|January 1, 1992
The classification of amblyopia on the basis of visual and oculomotor performanceS P McKee, C M Schor, S B Steinman, et al.
Journal of Medicinal Chemistry|April 15, 1994
The development of cyclic sulfolanes as novel and high-affinity P2 ligands for HIV-1 protease inhibitorsA K Ghosh, H Y Lee, W J Thompson, et al.
Drug Design and Discovery|January 1, 1993
HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimeticsA K Ghosh, S P McKee, W M Sanders, et al.
Journal of Medicinal Chemistry|April 2, 1993
Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitorsA K Ghosh, W J Thompson, H Y Lee, et al.
Journal of Medicinal Chemistry|August 6, 1993
Potent HIV protease inhibitors: the development of tetrahydrofuranylglycines as novel P2-ligands and pyrazine amides as P3-ligandsA K Ghosh, W J Thompson, M K Holloway, et al.
Journal of Medicinal Chemistry|January 22, 1993
3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitorsA K Ghosh, W J Thompson, S P McKee, et al.
Pageof 20